Some Ebola Patients Should Get Placebo in Drug Tests: FDA "Edward Cox, director of the FDA’s Office of Antimicrobial Products, said Wednesday that some patients with Ebola need to forgo potentially life-saving treatments so researchers can see how they fare compared to those who receive the experimental drugs .... Cox noted that randomised studies would be "challenging," but they are necessary ..."